5
Orphan Designations
0
FDA Approvals
10
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Balkan nephropathy | bispecific antibody (monoclonal antibody) | Orphan Designation | - |
| HER2 positive breast carcinoma | bispecific antibody (monoclonal antibody) | Orphan Designation | - |
| Her2-receptor negative breast cancer | bispecific antibody (monoclonal antibody) | Orphan Designation | - |
| gastroesophageal junction adenocarcinoma | bispecific antibody (monoclonal antibody) | Orphan Designation | - |
| hormone receptor-positive breast cancer | bispecific antibody (monoclonal antibody) | Orphan Designation | - |
| malignant carotid body paraganglioma | Anti-Claudin 18.2 antibody drug conjugate comprised of a Claudin 18.2 targeting monoclonal IgG1 antibody, a linker LND1002, and monomethyl auristatin E | Orphan Designation | - |
| malignant pancreatic neoplasm | Anti-Claudin 18.2 Antibody Drug Conjugate with MMAE and LND1002 linker | Orphan Designation | - |
| post-treatment Lyme disease syndrome | Anti-Claudin 18.2 antibody drug conjugate comprised of a Claudin 18.2 targeting monoclonal IgG1 antibody, a linker LND1002, and monomethyl auristatin E | Orphan Designation | - |
| treatment-refractory schizophrenia | Anti-Claudin 18.2 antibody drug conjugate comprised of a Claudin 18.2 targeting monoclonal IgG1 antibody, a linker LND1002, and monomethyl auristatin E | Orphan Designation | - |
| triple-positive breast carcinoma | bispecific antibody (monoclonal antibody) | Orphan Designation | - |